the following segment information is presented for Drug Development and Commercialization; and Compounded Pharmaceuticals. (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Segment Reporting Information [Line Items]
Assets	$ 63,707,484	$ 30,867,462	$ 63,707,484	$ 30,867,462	$ 30,867,462
Capital Expenditures	377,365	301,234	811,123	453,100
Depreciation and amortization	678,603	878,105	1,325,764	1,795,305
Drug Development and Commercialization [Member]
Segment Reporting Information [Line Items]
Assets	46,890,167		46,890,167		13,027,945
Capital Expenditures	362,055	260,427	795,812	319,513
Depreciation and amortization	368,960	565,882	696,867	1,171,452
Compounded Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Assets	16,817,317		16,817,317		$ 17,839,517
Capital Expenditures	15,310	40,807	15,311	133,587
Depreciation and amortization	$ 309,643	$ 312,223	$ 628,897	$ 623,853